Posner–Schlossman syndrome
Posner–Schlossman syndrome (PSS), also known as glaucomatocyclitic crisis, is a rare condition characterized by recurrent episodes of elevated intraocular pressure (IOP) and mild anterior uveitis.
Symptoms[edit]
The primary symptom of PSS is a sudden onset of unilateral, mild to moderate eye pain. Other symptoms may include blurred vision, halos around lights, and mild redness of the eye. The symptoms usually resolve within a few days to a few weeks, but can recur at any time.
Causes[edit]
The exact cause of PSS is unknown. It is thought to be an autoimmune disorder, in which the body's immune system mistakenly attacks the tissues of the eye. Some researchers believe that a viral infection may trigger the immune response.
Diagnosis[edit]
Diagnosis of PSS is based on the clinical symptoms and findings on eye examination. The key diagnostic feature is an elevated IOP in the presence of a mild anterior uveitis. Other tests may include gonioscopy, visual field testing, and optical coherence tomography.
Treatment[edit]
Treatment of PSS is aimed at reducing the IOP and controlling the inflammation. This may involve the use of topical corticosteroids and IOP-lowering medications. In some cases, surgery may be required to control the IOP.
Prognosis[edit]
The prognosis for PSS is generally good. Most people with PSS have a normal life expectancy and good vision. However, some people may develop glaucoma and require ongoing treatment to control the IOP and prevent vision loss.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
